| 05/10/23 | 14:15:01 | 5 Oct 2023 | | Notice of rescheduled AGM | RNS |
| 02/10/23 | 13:30:01 | 2 Oct 2023 | | Liquidity Agreement and Total Voting Rights | RNS |
| 28/09/23 | 15:15:01 | 28 Sept 2023 | | Reminder to shareholders re. AGM voting | RNS |
| 28/09/23 | 07:00:07 | 28 Sept 2023 | | 2023 Interim Results | RNS |
| 14/09/23 | 07:00:02 | 14 Sept 2023 | | AGM voting | RNS |
| 13/09/23 | 07:00:07 | 13 Sept 2023 | | Notice of Results | RNS |
| 11/09/23 | 07:55:01 | 11 Sept 2023 | | Cancellation of trading of Yourgene Shares | RNS |
| 08/09/23 | 12:00:46 | 8 Sept 2023 | | Completion of acquisition of Yourgene Health plc | RNS |
| 07/09/23 | 12:22:10 | 7 Sept 2023 | | Court sanction of the Scheme of Arrangement | RNS |
| 01/09/23 | 12:30:02 | 1 Sept 2023 | | Liquidity Agreement and Total Voting Rights | RNS |
| 29/08/23 | 07:00:08 | 29 Aug 2023 | | Notice of rescheduled AGM | RNS |
| 17/08/23 | 17:16:29 | 17 Aug 2023 | | Acquisition update | RNS |
| 01/08/23 | 11:45:01 | 1 Aug 2023 | | Liquidity Agreement and Total Voting Rights | RNS |
| 27/07/23 | 07:00:06 | 27 Jul 2023 | | Half Year Trading Update | RNS |
| 13/07/23 | 07:00:06 | 13 Jul 2023 | | Notice of cancelled AGM | RNS |
| 03/07/23 | 12:00:02 | 3 Jul 2023 | | Liquidity Agreement and Total Voting Rights | RNS |
| 03/07/23 | 07:01:21 | 3 Jul 2023 | | Recommended cash offer for Yourgene Health plc | RNS |
| 15/06/23 | 16:00:01 | 15 Jun 2023 | | Notice of rescheduled AGM | RNS |
| 12/06/23 | 07:00:07 | 12 Jun 2023 | | Reminder to shareholders re. AGM voting | RNS |
| 01/06/23 | 13:00:02 | 1 Jun 2023 | | Liquidity Agreement and Total Voting Rights | RNS |
| 26/05/23 | 07:00:04 | 26 May 2023 | | Publication of Annual Report and AGM voting | RNS |
| 10/05/23 | 07:00:09 | 10 May 2023 | | Notice of AGM | RNS |
| 02/05/23 | 12:30:02 | 2 May 2023 | | Total Voting Rights | RNS |
| 27/04/23 | 07:00:07 | 27 Apr 2023 | | Final Results | RNS |
| 17/04/23 | 07:00:07 | 17 Apr 2023 | | Notice of Results | RNS |
| 03/04/23 | 13:00:04 | 3 Apr 2023 | | Liquidity Agreement and Total Voting Rights | RNS |
| 01/03/23 | 16:15:01 | 1 Mar 2023 | | Liquidity Agreement and Total Voting Rights | RNS |
| 01/02/23 | 13:30:01 | 1 Feb 2023 | | Liquidity Agreement and Total Voting Rights | RNS |
| 30/01/23 | 07:00:03 | 30 Jan 2023 | | DHSC Claim update – Trial date listed | RNS |
| 26/01/23 | 07:00:06 | 26 Jan 2023 | | Full Year 2022 Trading Update | RNS |
| 06/01/23 | 12:15:01 | 6 Jan 2023 | | Holdings in Company | RNS |
| 03/01/23 | 12:30:01 | 3 Jan 2023 | | Liquidity Agreement and Total Voting Rights | RNS |
| 07/12/22 | 07:00:08 | 7 Dec 2022 | | Non-Executive Director Change | RNS |
| 06/12/22 | 07:00:06 | 6 Dec 2022 | | Approval of genesig COVID-19 3G PCR test in UK | RNS |
| 01/12/22 | 17:00:06 | 1 Dec 2022 | | Liquidity Agreement and Total Voting Rights | RNS |
| 10/11/22 | 07:00:12 | 10 Nov 2022 | | Directorate Change | RNS |
| 01/11/22 | 17:00:01 | 1 Nov 2022 | | Liquidity Agreement and Total Voting Rights | RNS |
| 27/10/22 | 18:45:00 | 27 Oct 2022 | | CORRECTION: UK CTDA approval of Winterplex 3G | RNS |
| 26/10/22 | 07:00:04 | 26 Oct 2022 | | UK Approval of genesig® SARS-CoV-2 Winterplex® 3G | RNS |
| 03/10/22 | 15:30:01 | 3 Oct 2022 | | Liquidity Agreement and Total Voting Rights | RNS |
| 29/09/22 | 07:00:12 | 29 Sept 2022 | | Half year 2022 results | RNS |
| 15/09/22 | 07:00:14 | 15 Sept 2022 | | Notice of Results and Investor Presentation | RNS |
| 01/09/22 | 12:00:06 | 1 Sept 2022 | | Liquidity Agreement and Total Voting Rights | RNS |
| 04/08/22 | 07:00:09 | 4 Aug 2022 | | Launch of first fully lyophilised PROmate® assays | RNS |
| 01/08/22 | 14:30:01 | 1 Aug 2022 | | Liquidity Agreement and Total Voting Rights | RNS |
| 28/07/22 | 07:00:18 | 28 Jul 2022 | | Launch of research-use-only adenovirus F41 assay | RNS |
| 20/07/22 | 15:00:05 | 20 Jul 2022 | | Results of AGM | RNS |
| 15/07/22 | 07:00:06 | 15 Jul 2022 | | Director/PDMR Shareholding | RNS |
| 15/07/22 | 07:00:05 | 15 Jul 2022 | | Approval of exsig™ COVID-19 Direct test in the UK | RNS |
| 07/07/22 | 15:00:06 | 7 Jul 2022 | | Director/PDMR Shareholding | RNS |
